Byrne Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1K | Sell |
660
-450
| -41% | -$7.54K | 0.01% | 391 |
|
|
2025
Q1 | $17.1K | Hold |
1,110
| – | – | 0.01% | 357 |
|
|
2024
Q4 | $24.5K | Sell |
1,110
-2,100
| -65% | -$46.3K | 0.02% | 265 |
|
|
2024
Q3 | $57.8K | Hold |
3,210
| – | – | 0.04% | 188 |
|
|
2024
Q2 | $52.2K | Buy |
+3,210
| New | +$52.2K | 0.04% | 192 |
|
|
2023
Q4 | – | Sell |
-200
| Closed | -$2K | – | 578 |
|
|
2023
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 486 |
|
|
2023
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 560 |
|
|
2023
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 565 |
|
|
2022
Q4 | $1.82K | Hold |
200
| – | – | ﹤0.01% | 495 |
|
|
2022
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 478 |
|
|
2022
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 496 |
|
|
2022
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 505 |
|
|
2021
Q4 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 505 |
|